Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab

Introduction: Myasthenia gravis (MG) is an antibody mediated autoimmune neuromuscular disorder characterized by fatigable muscle weakness. A proportion of myasthenia gravis patients are classified as refractory due to non responsiveness to conventional treatment. This retrospective study was done to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudulagunta, Sreenivasa Rao, Sepehrar, Mona, Sodalagunta, Mahesh Babu, Settikere Nataraju, Aravinda, Bangalore Raja, Shiva Kumar, Sathyanarayana, Deepak, Gummadi, Siddharth, Burra, Hemanth Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067337/
https://www.ncbi.nlm.nih.gov/pubmed/27790079
http://dx.doi.org/10.3205/000239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067337/
https://www.ncbi.nlm.nih.gov/pubmed/27790079
http://dx.doi.org/10.3205/000239

Ejemplares similares